Adriamycin (40 mg/m2 i.v., on day 1) plus cyclophosphamide (200 mg/m2 orally, day 1 to 5) were given to 23 patients with advanced lung cancer. Administration cycles were repeated every 3 weeks. No patient had been previously treated with chemotherapy, 5 received prior radiotherapy. Objective improvement was observed in 7 patients, partial remission was observed in 3. The median duration of response was 2 months.
Get full access to this article
View all access options for this article.
References
1.
BonadonnaG.BerettaG.TanciniG.De LenaM.De PaloG. M.GaspariniM.DociR.: Monochemioterapia con adriamicina in varie neoplasie in fase avanzata dell'adulto e del bambino. Tumori, 60: 373–391, 1974.
2.
De VitaV. T.YoungR. C.CanellosG.: Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancer. Cancer, 35: 98–110, 1975.
3.
JonesS. E.DurieB. G. M.SalmonS. E.: Combination chemotherapy with Adriamycin and Cyclophosphamide for advanced breast cancer. Cancer, 36: 90–97, 1975.
4.
LloydR. E.JonesS. E.SalmonS. E. Southwest Oncology Group Members: Phase II trial of Adriamycin and Cyclophosphamide: A Southwest Oncology Group Pilot Study. Am. Ass. Cancer Res. - Am. Soc. Clin. Oncol. Proc., 16: 265, 1975.
5.
LokichJ.ParkerL.FreiE.III: Adriamycin and Cyclophosphamide combination chemotherapy. Abstr., pp. 369–370, vol. 1. Proc. Cancer Congress, Florence, 1974.
6.
SelawryO. S.: The role of chemotherapy in the treatment of lung cancer. Semin. Oncol., 1: 259–272, 1974.
7.
SelawryO. S.: Response of bronchogenic carcinoma to Adriamycin (NSC-123127). Cancer Chemother. Rep., 6: 349–351, 1975.
8.
SelawryO. S.: Polichemotherapy with Adriamycin (NSC-123127) in bronchogenic carcinoma. Cancer Chemother. Rep., 6: 352–359, 1975.
9.
TanciniG.BajettaE.BonadonnaG.: Terapia con Bleomicina da sola o in associazione con Methotrexate nel carcinoma epidermoide dell'esofago. Tumori, 60: 65–71, 1974.
10.
WolfJ.ZelenM.: Comparative trial of two drug combination in pulmonary cancer. Am. Ass. Cancer Res. - Am. Soc. Clin. Oncol. Proc., 16: 272, 1975.
